XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Disaggregation of Revenue [Line Items]          
Net sales $ 6,057 $ 5,494 $ 17,945 $ 16,159  
Contract liabilities $ 939   $ 939   $ 978
Other Orthopedics - Enabling Technologies          
Disaggregation of Revenue [Line Items]          
Net sales   32   94  
Neuro Cranial - Interventional Spine          
Disaggregation of Revenue [Line Items]          
Net sales   $ 100   $ 296  
Customer Lease Agreements | Revenue Benchmark | Product Concentration Risk          
Disaggregation of Revenue [Line Items]          
Concentration risk (as a percent) 4.00% 4.00% 4.00% 4.00%